93 results
424B5
ARWR
Arrowhead Pharmaceuticals Inc.
4 Jan 24
Prospectus supplement for primary offering
5:01pm
. Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more
S-3ASR
ARWR
Arrowhead Pharmaceuticals Inc.
2 Dec 22
Automatic shelf registration
9:23pm
to target and shut down specific disease-causing genes. Arrowhead is focused on developing innovative drugs for diseases with a genetic basis, typically … on developing innovative drugs for diseases with a genetic basis, typically characterized by the overproduction of one or more proteins that are involved
8-K
EX-99.1
jjn32i 57snavnxq
4 Aug 22
Arrowhead Pharmaceuticals Reports Fiscal 2022 Third Quarter Results
4:08pm
8-K
EX-99.1
sdrni ptgk9hcj
10 May 22
Arrowhead Pharmaceuticals Reports Fiscal 2022 Second Quarter Results
4:06pm
8-K
r6kjpcn6icrigb7t
25 Apr 22
Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market
7:31am
8-K
EX-99.1
thwi 26a96
25 Apr 22
Arrowhead Pharmaceuticals and Vivo Capital Launch Joint Venture Aimed at Greater China Market
7:31am
8-K
EX-99.1
7bgy54 o7nl
22 Jun 21
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
4:09pm
8-K
EX-99.1
49ehohfdppca522
9 Oct 20
Takeda and Arrowhead Collaborate to Co-Develop and Co-Commercialize ARO-AAT for Alpha-1 Antitrypsin-Associated Liver Disease
5:00pm
424B5
nr0czyigp
5 Aug 20
Prospectus supplement for primary offering
5:14pm